解題
### (a) Define the term *external growth*.
External growth (also known as inorganic growth) refers to a business expanding its operations by integrating, merging, acquiring, or forming strategic alliances/joint ventures with other external business entities. Unlike organic growth, which relies on internal resources, external growth achieves rapid expansion using the capabilities of other firms.
### (b) Explain two advantages for EPL of remaining a private limited company rather than converting to a public limited company.
* **Retention of control:** As a private limited company (Ltd), EPL's shares cannot be traded on public stock exchanges, and existing shareholders must approve any sale of shares. This prevents hostile takeovers and allows the current owners (including CEO Maya Patel) to maintain strategic control over the business without pressure from public investors.
* **Lower regulatory and administrative costs:** Public limited companies (Plcs) face heavy regulatory requirements, flotation expenses, and must publish detailed, transparent financial accounts. By remaining an Ltd, EPL avoids these substantial setup and annual compliance costs, preserving capital to fund their growth options.
### (c) Using the Ansoff Matrix, analyze the risks and rewards of Option 2 (Smart Pharma Packaging).
Option 2 falls under **Diversification** on the Ansoff Matrix, as it involves launching a *new product* (smart packaging with RFID technology) into a *new market* (pharmaceutical logistics).
**Rewards:**
* **High growth and premium margins:** The pharmaceutical sector is highly profitable and less sensitive to economic downturns, allowing EPL to command premium prices.
* **Risk spreading:** Diversification ensures that EPL is not solely dependent on the organic food sector. If the domestic food packaging market declines, the pharmaceutical packaging segment provides alternative revenues.
* **Synergy and shared expertise:** By partnering with *PharmaTech*, EPL gains technological capabilities without having to develop them fully from scratch.
**Risks:**
* **Highest-risk strategy:** Diversification is the most high-risk quadrant in the Ansoff Matrix because EPL has no pre-existing expertise in RFID electronics or pharmaceutical regulations.
* **Brand dilution / failure cost:** A technical failure (e.g., faulty temperature sensors destroying a vaccine batch) could result in litigation, financial ruin, and damage EPL's green, trustworthy brand identity.
* **Integration and alliance risk:** Joint ventures often suffer from cultural differences, disagreements over profit-sharing, or IP disputes between the partner firms.
### (d) Evaluate whether EPL should choose Option 1 or Option 2 to achieve its strategic growth objectives.
**Option 1: Market Development**
* *Arguments for:* This strategy relies on EPL’s existing core competency: producing biodegradable packaging. The product is already successful, and the operations are established, representing a much lower operational risk. It leverages existing economies of scale.
* *Arguments against:* Exporting to the EU presents logistics challenges, exchange rate fluctuations, and trade barriers (tariffs/quotas post-Brexit). EPL will also have to compete with established local European packaging firms and adapt to different regulatory standards.
**Option 2: Diversification**
* *Arguments for:* The pharmaceutical sector offers rapid, high-margin growth. Using a joint venture with *PharmaTech* helps mitigate risk by sharing costs, technical skills, and resources.
* *Arguments against:* Diversification is notoriously difficult to execute. EPL is moving far from its green roots into high-tech hardware. The investment cost will be substantial, potentially straining EPL's cash flow.
**Conclusion / Evaluation:**
EPL's choice should align with its risk appetite and capital availability.
* If EPL seeks a safer, more sustainable growth path that protects its core brand and requires lower capital outlay, **Option 1 (Market Development)** is the preferred route. It allows them to capitalize on the widespread European shift toward green practices.
* However, if EPL has access to sufficient finance, strong intellectual property protection, and wishes to position itself as a long-term technology-driven innovator, **Option 2 (Diversification)** could be highly rewarding. On balance, given that EPL is currently a private limited company with likely limited capital compared to major Plcs, **Option 1** represents a more realistic, manageable, and strategically sound step before embarking on radical technological diversification.
評分準則
### Part (a) [2 Marks]
* **2 marks:** Clear, accurate definition showing full understanding of integration with external entities (e.g., mergers, acquisitions, joint ventures).
* **1 mark:** Partial or vague definition (e.g., "growing by working with others").
### Part (b) [4 Marks]
For each of the two advantages identified:
* **2 marks:** Advantage is clearly identified, explained, and directly applied to EPL's context.
* **1 mark:** Advantage is identified or explained in a generic way with no context or application.
### Part (c) [6 Marks]
* **5–6 marks:** Clear identification of Option 2 as diversification. Balanced, analytical discussion of both risks and rewards of this strategy, with good context-driven points.
* **3–4 marks:** Identification of diversification, but analysis is unbalanced (focuses only on risks or rewards) or lacks depth and specific application to EPL.
* **1–2 marks:** Superficial response with limited understanding of the Ansoff Matrix or the case study context.
### Part (d) [8 Marks]
* **7–8 marks:** Comprehensive evaluation of both options, with a balanced discussion of pros and cons. The response leads to a logical, well-justified recommendation that directly references EPL’s position as a private limited company.
* **5–6 marks:** Detailed discussion of both options, but evaluation is weak, lacks depth, or the recommendation is not fully supported by the arguments.
* **3–4 marks:** Descriptive response of the two options. Lacks balanced discussion and contains little to no genuine evaluation.
* **1–2 marks:** Highly limited, fragmented answer with minimal business management terminology.